Screener
Xenon Pharmaceuticals XENE Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's invested capital?
- Xenon Pharmaceuticals (XENE) reported invested capital of $1.13B in Q2 2026.
- How has Xenon Pharmaceuticals's invested capital changed year-over-year?
- Xenon Pharmaceuticals's invested capital increased by 122.6% year-over-year, from $507.31M to $1.13B.
- What is the long-term trend for Xenon Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's invested capital has grown at a 24.7% compound annual growth rate (CAGR), from $129.66M to $390.54M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Xenon Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude